EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+24.9%
5Y CAGR+30.8%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+24.9%/yr
vs +48.2%/yr prior
5Y CAGR
+30.8%/yr
Recent deceleration
Acceleration
-23.3pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.8x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$274.81M+45.3%
2024$189.13M+56.2%
2023$121.08M-14.1%
2022$141.04M+52.9%
2021$92.22M+28.6%
2020$71.73M+5.1%
2019$68.23M+133.4%
2018$29.23M+11.9%
2017$26.11M+11.6%
2016$23.39M-